{
    "clinical_study": {
        "@rank": "85855", 
        "arm_group": {
            "arm_group_label": "Ranibizumab with Photocoagulation", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the mean gain in best corrected visual acuity and\n      the number of intravitreal ranibizumab (IVR) injections under the combination treatment of\n      IVR, focal/grid laser and panretinal photocoagulation. Our hypothesis is that  suitable\n      photocoagulation decreases the number of IVR injections."
        }, 
        "brief_title": "Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula Edema", 
        "condition": "Diabetic Macula Edema", 
        "condition_browse": {
            "mesh_term": "Edema"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  stable medication for the management  of diabetes within 3 months\n\n          -  visual impairment due to focal or diffuse diabetic macula edema\n\n          -  decreased vision due to diabetic macula edema  and not other causes\n\n        Exclusion Criteria:\n\n          -  concomitant conditions in the study eye that could prevent the improvement in VA on\n             the study\n\n          -  active intraocular inflammation or infection in either eye\n\n          -  uncontrolled glaucoma in either eye\n\n          -  treatment with antiangiogenic drugs in the study eye within 3 months\n\n          -  history of stroke and uncontrolled hypertension"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 22, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02131350", 
            "org_study_id": "2617"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ranibizumab with Photocoagulation", 
                "description": "Photocoagulation include focal/grid laser and/or panretinal photocoagulation", 
                "intervention_name": "Photocoagulation", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Ranibizumab with Photocoagulation", 
                "intervention_name": "Ranibizumab", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 2, 2014", 
        "location": {
            "contact": {
                "email": "ieganka@shinshu-u.ac.jp", 
                "last_name": "Takao Hirano", 
                "phone": "+81-263-37-2664"
            }, 
            "facility": {
                "address": {
                    "city": "Matsumoto", 
                    "country": "Japan", 
                    "state": "Nagano", 
                    "zip": "3908621"
                }, 
                "name": "Department ou Ophthalmology Shinshu University School of Medicine"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "1", 
        "overall_contact": {
            "email": "murata@shinshu-u.ac.jp", 
            "last_name": "Toshinori Murata", 
            "phone": "+81-263-37-2664"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Japan: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Best corrected visual acuity is measured with Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity chart and analysed.", 
            "measure": "best corrected visual acuity", 
            "safety_issue": "Yes", 
            "time_frame": "every month, up to 36 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02131350"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shinshu University", 
            "investigator_full_name": "Takao Hirano", 
            "investigator_title": "Department of Ophthalmology Shinshu University School of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Shinshu University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shinshu University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}